ISUPREL
LOE ApproachingNDAINJECTIONINJECTABLEPriority Review
Approved
May 1956
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Priority Review
Drug data last refreshed 3h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
ISUPREL is an injectable medication approved in 1956 by Bausch + Lomb as an NDA product. The specific mechanism of action and indications are not publicly detailed in available data, but the injectable formulation suggests acute or emergency use. As a legacy product with approaching loss of exclusivity, it likely serves a specialized clinical population.
LOE Approaching
As a legacy injectable approaching LOE with minimal linked job postings, the commercial team is likely small and focused on managed care defense rather than growth initiatives.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
With zero linked job postings and approaching LOE, ISUPREL offers limited career growth opportunities; roles available are primarily defensive (managed care, channel optimization, supply management). This is a legacy product suitable for mid-career professionals managing mature portfolios or those transitioning into post-LOE business models.
Brand ManagerAccount Manager
Worked on ISUPREL at Bausch + Lomb? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.